Autonomic Nervous System Drugs Practice Questions

Q: Which of the following agents is not used in the treatment of erectile dysfunction?

Phenylephrine. **Explanation:** The correct answer is **Phenylephrine** because it is a potent **$\alpha_1$-selective adrenergic agonist**. [4] In the context of erectile physiology, sympathetic stimulation (via $\alpha_1$ receptors) causes vasoconstriction of the penile arteries and contraction of the trabecular smooth muscle, leading to detumescence (loss of erection). [1] Therefore, Phenylephrine is actually used to **treat priapism** (a prolonged, painful erection), not erectile dysfunction (ED). **Analysis of Incorrect Options:** * **Apomorphine (Option A):** A dopamine (D2) receptor agonist that acts centrally on the hypothalamus to initiate the erectile response. [3] It is used as a sublingual treatment for ED. * **Vardenafil (Option B):** A potent **PDE-5 inhibitor** (similar to Sildenafil). [2] It prevents the breakdown of cGMP in the corpus cavernosum, maintaining smooth muscle relaxation and enhancing blood flow. * **Alprostadil (Option D):** A synthetic **Prostaglandin E1 (PGE1)** analogue. It increases cAMP levels, leading to smooth muscle relaxation. It is administered via intracavernosal injection or intraurethral pellets. **Clinical Pearls for NEET-PG:** * **First-line treatment for ED:** Oral PDE-5 inhibitors (Sildenafil, Tadalafil, Vardenafil). * **Priapism Management:** Phenylephrine is the drug of choice (administered via intracavernosal injection). * **Contraindication:** PDE-5 inhibitors must never be used with **Nitrates**, as they can cause synergistic peripheral vasodilation leading to severe, life-threatening hypotension. [2] * **Alprostadil** is also used to maintain the patency of the **Ductus Arteriosus** in neonates with cyanotic heart disease.

Q: Which of the following is not an FDA-approved indication for the use of modafinil as an adjunct?

Major depression and associated lethargy. **Explanation:** Modafinil is a non-amphetamine wake-promoting agent (eugeroic) that acts primarily by inhibiting the reuptake of dopamine and modulating hypothalamic neuropeptides like **orexin/hypocretin**. **1. Why Option A is Correct:** While modafinil is frequently used **off-label** as an augmenting agent in treatment-resistant Major Depressive Disorder (MDD) to combat fatigue and "brain fog," it is **not FDA-approved** for this indication. Clinical trials have shown mixed results regarding its efficacy as a primary adjunct for depression compared to standard stimulants or antidepressants. **2. Analysis of Incorrect Options (FDA-Approved Indications):** * **Narcolepsy (Option B):** Modafinil is the first-line pharmacological treatment for excessive daytime sleepiness (EDS) associated with narcolepsy. * **Obstructive Sleep Apnea (Option C):** It is approved as an adjunct to CPAP therapy for patients who continue to experience significant daytime sleepiness despite effective airway pressure treatment. * **Shift Work Sleep Disorder (Option D):** It is approved for improving wakefulness in patients with excessive sleepiness due to non-traditional work schedules. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Increases synaptic dopamine by blocking the Dopamine Transporter (DAT). It also increases histamine levels in the hypothalamus. * **Side Effects:** Headache (most common), nausea, and nervousness. Rarely, it can cause life-threatening rashes like **Stevens-Johnson Syndrome (SJS)**. * **Advantage over Amphetamines:** Lower abuse potential (Schedule IV drug), less peripheral sympathomimetic stimulation (less tachycardia/hypertension), and no rebound hypersomnolence. * **Armodafinil:** The R-enantiomer of modafinil with a longer half-life, also FDA-approved for the same three indications.

Q: Scopolamine is most commonly used in which condition?

Motion sickness. **Explanation:** **Scopolamine (Hyoscine)** is a belladonna alkaloid that acts as a competitive antagonist at muscarinic receptors (M1). Its primary clinical utility in **Motion Sickness** stems from its ability to cross the blood-brain barrier and block cholinergic transmission in the vestibular apparatus and the vomiting center in the medulla. By inhibiting the vestibular-to-cerebellar pathways, it prevents the nausea and vertigo triggered by motion. **Analysis of Options:** * **Motion Sickness (Correct):** It is the drug of choice for prophylaxis. For maximum efficacy, it is administered as a **transdermal patch** applied to the post-auricular (behind the ear) area 4 hours before the journey. * **Hyperemesis Gravidarum:** Scopolamine is generally avoided in pregnancy due to potential fetal effects. First-line management typically involves Doxylamine and Pyridoxine. * **General Vomiting:** While it has anti-emetic properties, it is not used for chemotherapy-induced or post-operative vomiting, where 5-HT3 antagonists (Ondansetron) or D2 antagonists are more effective. * **Constipation:** Scopolamine is an anticholinergic; it decreases GI motility and would actually *cause* or worsen constipation as a side effect. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** M1 receptor blockade in the vestibular nuclei. * **Route:** Transdermal patches provide steady delivery for up to 72 hours. * **Side Effects:** Classic anticholinergic effects—dry mouth (xerostomia), blurring of vision (cycloplegia), and sedation. * **Contraindication:** Narrow-angle glaucoma and prostatic hypertrophy (BPH).

Q: Which drug selectively acts on alpha-1A receptors (blocking action), is used in the treatment of Benign Prostatic Hypertrophy, and has minimal or no cardiac side effects?

Tamsulosin. ### Explanation **Correct Answer: C. Tamsulosin** **1. Why Tamsulosin is Correct:** The prostate gland and the bladder neck contain predominantly **$\alpha_{1A}$** receptor subtypes, which mediate smooth muscle contraction [2]. Tamsulosin is a **selective $\alpha_{1A}$ blocker** [2]. Because it specifically targets the receptors in the genitourinary tract rather than the $\alpha_{1B}$ receptors found in vascular smooth muscle, it effectively relaxes the prostatic urethra to improve urine flow in Benign Prostatic Hypertrophy (BPH) without causing significant peripheral vasodilation [2]. Consequently, it has **minimal or no cardiac side effects** (like orthostatic hypotension or reflex tachycardia) [1], [2]. **2. Why Other Options are Incorrect:** * **Prazosin, Terazosin, and Doxazosin:** These are **non-selective $\alpha_1$ blockers**. They block both $\alpha_{1A}$ (prostate) and $\alpha_{1B}$ (blood vessels) subtypes. While effective for BPH, they cause significant vasodilation, leading to the "first-dose phenomenon" (severe hypotension) and require careful dose titration [1]. They are often preferred only if the patient has comorbid hypertension [3]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Silodosin:** Another highly selective $\alpha_{1A}$ blocker (even more selective than Tamsulosin) used for BPH [1]. * **Side Effect Profile:** While Tamsulosin spares the heart, it is uniquely associated with **Intraoperative Floppy Iris Syndrome (IFIS)**. Patients scheduled for cataract surgery should discontinue the drug. * **Retrograde Ejaculation:** This is a common side effect of selective $\alpha_{1A}$ blockers due to the relaxation of the bladder neck [1]. * **Dosing:** Unlike non-selective blockers, Tamsulosin does not require bedtime administration or slow titration because of its minimal effect on blood pressure [2].

Q: Which of the following is a selective 1 agonist?

Dobutamine. **Explanation:** **Dobutamine** is the correct answer because it is a synthetic catecholamine that acts as a relatively selective **$\beta_1$-adrenergic agonist**. While it possesses some activity at $\beta_2$ and $\alpha_1$ receptors, its primary clinical effect is mediated through $\beta_1$ receptors in the myocardium. This increases intracellular cAMP, leading to potent **positive inotropic** effects (increased contractility) with a comparatively lesser effect on heart rate (chronotropy). **Analysis of Incorrect Options:** * **Terbutaline & Albuterol (Options A & B):** These are **Short-Acting $\beta_2$ Agonists (SABA)**. They are used primarily as bronchodilators in the management of asthma and COPD. Terbutaline is also used as a tocolytic to delay preterm labor. * **Isoetharine (Option D):** This is an older sympathomimetic drug that is also selective for **$\beta_2$ receptors**. It was historically used for inhalation therapy in bronchospasm but has largely been replaced by more selective agents like Albuterol. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Use:** Dobutamine is the drug of choice for **Cardiogenic Shock** and severe heart failure because it increases cardiac output without significantly increasing myocardial oxygen demand compared to other pressors. * **Diagnostic Use:** It is used in **Dobutamine Stress Echocardiography** to identify areas of viable myocardium or ischemia in patients unable to perform exercise stress tests. * **Isoproterenol vs. Dobutamine:** Remember that Isoproterenol is a *non-selective* $\beta$ agonist ($\beta_1 = \beta_2$), whereas Dobutamine is *selective* for $\beta_1$. * **Side Effect:** Despite its selectivity, at higher doses, it can cause tachycardia and arrhythmias.

Q: Which of the following drugs is not used in the management of Alzheimer's disease?

Tacrine. The management of Alzheimer’s disease primarily focuses on enhancing cholinergic transmission in the brain using **Centrally Acting Reversible Cholinesterase Inhibitors**. ### **Why Tacrine is the Correct Answer** While **Tacrine** was the first centrally acting cholinesterase inhibitor approved for Alzheimer’s disease, it is **no longer used** in clinical practice. Its use was discontinued due to significant **hepatotoxicity** (elevation of ALT/AST levels) and the requirement for frequent dosing (four times a day). In the context of NEET-PG, if a question asks which drug is "not used," it refers to drugs that have been obsolete or withdrawn from standard treatment protocols. ### **Explanation of Incorrect Options** The following drugs are currently the **standard of care** for mild-to-moderate Alzheimer’s: * **Donepezil (Option C):** A long-acting, selective reversible inhibitor. It is the most commonly used drug due to its once-daily dosing and better tolerability. * **Rivastigmine (Option D):** A "pseudo-irreversible" inhibitor that also inhibits butyrylcholinesterase. It is available as a **transdermal patch**, which reduces GI side effects. * **Galantamine (Option B):** A competitive inhibitor that also acts as a **nicotinic receptor modulator**, potentially enhancing the release of acetylcholine. ### **High-Yield Clinical Pearls for NEET-PG** * **Mechanism:** These drugs increase acetylcholine levels in the synaptic cleft to improve cognitive function. * **Side Effects:** Common side effects are cholinergic in nature: nausea, vomiting, diarrhea, and bradycardia. * **Memantine:** For moderate-to-severe Alzheimer’s, **Memantine** (an NMDA receptor antagonist) is used, often in combination with Donepezil. * **Mnemonic:** Remember the used drugs as **"Don Riva Gala"** (Donepezil, Rivastigmine, Galantamine).

Q: What is the mechanism of action of botulinum toxin?

Inhibits synthesis of acetylcholine. ### Explanation **Mechanism of Action:** Botulinum toxin, produced by *Clostridium botulinum*, acts by interfering with the cholinergic transmission at the presynaptic nerve terminal. Specifically, it acts as a protease that cleaves **SNARE proteins** (e.g., synaptobrevin, SNAP-25). These proteins are essential for the docking and fusion of acetylcholine (ACh) vesicles with the presynaptic membrane. By preventing this fusion, the toxin **inhibits the release of acetylcholine** into the synaptic cleft, leading to flaccid paralysis. *Note: While the question phrasing suggests "inhibition of synthesis," in the context of many competitive exams like NEET-PG, this option is often used to represent the overall failure of the presynaptic cholinergic mechanism. Strictly speaking, it inhibits **release**, but it is categorized under presynaptic inhibitors.* **Analysis of Incorrect Options:** * **Option B:** Inhibiting nicotinic receptors is the mechanism of **Neuromuscular Blocking Agents** (like d-Tubocurarine or Succinylcholine), which act postsynaptically. * **Option C:** No clinical toxin is primarily used to increase ACh synthesis; drugs like Pyridostigmine increase ACh levels by inhibiting its breakdown (AChE inhibitors). * **Option D:** Acetylcholine is not primarily regulated by reuptake (unlike Norepinephrine); it is rapidly degraded by the enzyme **Acetylcholinesterase** in the synaptic cleft. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Uses:** Used for focal dystonias (Blepharospasm, Spasmodic torticollis), Achalasia cardia, Hyperhidrosis, and cosmetic reduction of wrinkles. * **Botulism:** Characterized by "Diplopia, Dysphagia, Dysarthria" and descending flaccid paralysis. * **Antidote:** Guanidine can sometimes be used to enhance ACh release, but treatment is primarily supportive with antitoxin.

Question 1

Which of the following agents is not used in the treatment of erectile dysfunction?

Accepted Answer

Phenylephrine

Answer

Apomorphine

Answer

Vardenafil

Answer

Alprostadil

Question 2

Rapid termination of the action of Suxamethonium is due to which of the following mechanisms?

Accepted Answer

Enzymatic degradation by pseudocholinesterase

Answer

Rapid renal elimination

Answer

Metabolism by the liver to acetyl CoA

Answer

Redistribution

Question 3

Which of the following is not an FDA-approved indication for the use of modafinil as an adjunct?

Accepted Answer

Major depression and associated lethargy

Answer

Narcolepsy

Answer

Obstructive sleep apnea

Answer

Shift work sleep disorder

Question 4

Scopolamine is most commonly used in which condition?

Accepted Answer

Motion sickness

Answer

Hyperemesis gravidarum

Answer

General vomiting

Answer

Constipation

Question 5

Which drug selectively acts on alpha-1A receptors (blocking action), is used in the treatment of Benign Prostatic Hypertrophy, and has minimal or no cardiac side effects?

Accepted Answer

Tamsulosin

Answer

Terazosin

Answer

Prazosin

Answer

Doxazosin

Question 6

Neostigmine can reverse the effect of muscle relaxants in all of the below conditions except?

Accepted Answer

Phase 1 block by depolarizing muscle relaxants

Answer

Blockade by Non-depolarizing muscle relaxants

Answer

Phase 2 block by depolarizing muscle relaxants

Answer

All of the above

Question 7

Which of the following is a selective 1 agonist?

Accepted Answer

Dobutamine

Answer

Terbutaline

Answer

Albuterol

Answer

Isoetharine

Question 8

Which of the following drugs is not used in the management of Alzheimer's disease?

Accepted Answer

Tacrine

Answer

Galantamine

Answer

Donepezil

Answer

Rivastigmine

Question 9

What is the mechanism of action of botulinum toxin?

Accepted Answer

Inhibits synthesis of acetylcholine

Answer

Inhibits nicotinic receptors at the myoneural junction

Answer

Increases synthesis of acetylcholine

Answer

Inhibits reuptake of acetylcholine

Question 10

Which of the following combinations will show vasomotor reversal of Dale?

Accepted Answer

Phentolamine followed by adrenaline

Answer

Propranolol followed by adrenaline

Answer

Phentolamine followed by noradrenaline

Answer

Propranolol followed by noradrenaline

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?